lead news picture

Merck KGaA to buy Sigma–Aldrich

26 September 2014  Business

$17bn acquisition expands Merck’s life science business and US presence, but it isn’t stepping back from drug development


AbbVie backs out of Shire deal

17 October 2014 Business

news image

Treasury rule changes make inversion ‘too uncertain’ and remove financial benefits

Indian manufacturers hit back over quality claims

17 October 2014 Business

news image

Study showing drugs exported to Africa are substandard prompts backlash from generic drugmakers

Bio-based chemicals on the rise in US

16 October 2014 Business

news image

Government predicts 10% of chemicals market will be renewable by 2015

Endo outbids QLT for Auxilium merger  

Biotech backs out of Canadian deal in favour of increased $2.6bn bid from Endo

EMA finalises trial transparency rules  

Researcher access reinstated, but company redaction rights may cause issues

Actavis boosts antibiotics with Durata buyout  

$820 million deal gives Actavis control of newly-approved intravenous antibiotic

US tax changes ripple into merger deals  

Efforts to curb tax-avoiding ‘inversion’ deals will slow, but not stop, the wave

Becton Dickinson to buy CareFusion for $12bn  

Medical devices merger continues consolidation trend


More business news